High-resolution electron spin resonance spectra of semiquinones from daunomycin and its derivatives, daunomycinone and 7-deoxydaunomycinone, have been obtained during reduction by xanthine/xanthine oxidase or dithionite in partially nonaqueous media. Hyperfine coupling constants were assigned with the help of an experiment in deuterated solvent to observe the exchangeable protons and with the help of computer routines for the automatic assignment of hyperfine coupling constants. In contrast, in buffer the ESR spectrum of the daunomycin was a single broad line and that of the 7-deoxydaunomycinone exhibited axial symmetry showing strong g-factor anisotropy. The differences in the ESR spectra of the daunomycin semiquinone and its derivatives and the effects of the nonaqueous solvents ethanol and dimethyl sulfoxide are discussed. Daunomycin belongs to the widespread family of anthracycline drugs used in anticancer treatment. Because of the widespread use of daunomycin, a large number of investigations have been reported in recent years, and clinical as well as molecular aspects have been recently reviewed.'-s Since daunomycin is a quinone compound, it is a redox active molecule, one of its reaction pathways is the one-electron reduction to a semiquinone free radical. These radicals have been proposed to attack D N A site-specifically and produce strand breaks by producing reactive oxygen radicals such as the superoxide or the hydroxyl radicaL6s7 Additionally, oxygen-derived free radicals have been proposed to be responsible for the use-restricting cardiotoxicity of the drug, which has been attr ibuted to low levels of defensive enzymes against oxygen damage in the heart.* Previously, the E S R technique of spin-trapping has been employed to detect daunomycin-dependent superoxide and hydroxyl radical Since daunomycin is an anthraquinone derivative and, like most quinones, is easily reduced to its semiquinone free radical, direct E S R has been used to detect semiquinones of daunomycin and its derivative^.'^'^ Whereas the E S R spectra of enzymatically generated anthracycline semiquinones consist of a single, unresolved line,10-12 those obtained from chemical reduction of ant h r a ~ y c l i n e s ' ~ ~ ~ reveal hyperfine structure. Because of this distinct difference in E S R spectra, there exists a structural dilemma as 'National Institute for Environmental Health Sciences. Present address: Department of Chemistry, Luther College, Decorah, IA 52101. ~ ~ ~~~~~ *Present address: Laboratory of Clinical Pharmacology, National Cancer *Medical College of Wisconsin. Institute, National Institutes of Health, Bethesda, MD 20205. to the true identity of the semiquinones derived from daunomycin, especially in enzymatic systems. In an attempt to resolve this, we have now undertaken a study involving enzymatic reduction of anthracyclines in solutions of buffer and dimethyl sulfoxide or ethanol. W e have chosen the xanthine/xanthine oxidase reduction system for the following reasons: (i) xanthine oxidase has previously been shown to be involved during myocardial reduction of anthracyclines, and (ii) the xanthine oxidase was still active in the presence of up to 50% dimethyl sulfoxide. W e now report, for the first time, (1) Abdella, B. R. J.; Fisher, J . Enuiron. Health Perspecr. 198S, 64, 3-18. (2) Arcamone, F. Med. Res. Rev. 1984, 4, 153-188. (3) Aubel-Sadron, G.; Londos-Gagliardi, D. Biochimie 1984,66, 333-352. (4) Favaudon, V. Biochimie 1982, 64, 457-475. (5) Young, R. C.; Ozols, R. F.; Myers, C. E. N . Engl. J . Med. 1981,305, (6) Bates, D. A.; Winterbourn, C. C. Biochem. J . 1982, 203, 155-160. (7) Winterbourn, C. C. FEBS Lett. 1981, 136, 89-94. (8) Doroshow, J . H. Cancer Res. 1983, 43, 4543-4551. (9) Lown, J. W.; Chen, H.-H. Can. J . Chem. 1981, 59, 390-395. (IO) Gutibrrez, P. L.; Gee, M. V.; Bachur, N. R. Arch. Biochem. Biophys. (1 1) Kalyanaraman, B.; Peres-Reyez, E.; Mason, R. P. Biochim. Biophys. (12) Sinha, B . K.; Gregory, J. L. Biochem. Pharmacal. 1981, 30, (13) Kleyer, D. L.; Koch, T. H. J . Am. Chem. SOC. 1984,106,2380-2387. (14) Lown, J. W.; Chen, H.-H. Can. J . Chem. 1981, 59, 3212-3217. (15) Sinha, B. K.; Chignell, C. F. Chem.-Biol. Interact. 1979, 28, 301-308. (16) Sinha, B. K. Chem.-Biol. Interact. 1980, 30, 67-77. (17) Doroshow, J . H. Cancer Res. 1983, 43, 460-472. 139-1 53.
Read full abstract